DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 76 filers reported holding DYNE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,193 | -25.5% | 190,363 | -25.1% | 0.00% | -50.0% |
Q4 2022 | $2,945 | -99.7% | 254,110 | +210.1% | 0.00% | +100.0% |
Q3 2022 | $1,041,000 | +28.5% | 81,951 | +112.4% | 0.00% | 0.0% |
Q4 2020 | $810,000 | -79.3% | 38,590 | -80.1% | 0.00% | -80.0% |
Q3 2020 | $3,918,000 | – | 194,065 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |